Sarepta Therapeutics logo
Sarepta Therapeutics
SRPT | NASDAQ
Chart Builder DCF Calculator
$15.13
-$0.94 (-5.85%)
At close: Nov 16, 2026, 4:00 PM ET
$15.20
+$0.07 (+0.46%)
After-hours: Nov 16, 2026, 7:30 PM ET

Sarepta Therapeutics Institutional Ownership

Institutional ownership explained

Institutional Ownership

Net Inflow
Dollar & Volume Weighted
Total Institutions
349
Total Ownership
103.01%
Capital Flow
+$284.47M
Shares Change
+5.6M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)

Institutional Sentiment

Overall: bearish
Equity Sentiment & Activity
neutral
New Positions
49
Increased Positions
151
Reduced Positions
118
Closed Positions
66
New (49)
Increased (151)
Reduced (118)
Closed (66)
Options Sentiment & Activity
bearish
Put/Call Ratio
1.331
Call Flow
2,327,965
Put Flow
3,097,700
Calls (43%)
Puts (57%)

Super Investors

Super Investor / Fund Ownership Portfolio Weight Shares Market Value
Renaissance Technologies LLC
1.06%
-32.65%
0.03%
1.12M
21.56M
Point72 Asset Management LP
0.48%
0.00%
0.01%
510.91K
9.82M
Bridgewater Associates LP
0.14%
+13.25%
0.01%
152.07K
2.92M

Top Shareholders

Institution Ownership Portfolio Weight Shares Market Value
Blackrock, Inc.
18.02%
+28.19%
< 0.01%
-9.58%
18.99M
+28.73%
341.34M
+6.31%
State Street Corp
8.49%
+34.82%
< 0.01%
-4.74%
8.92M
+34.82%
160.22M
+11.34%
Vanguard Portfolio Management LLC
7.95%
+25.62%
< 0.01%
-10.14%
8.38M
+26.15%
150.54M
+4.18%
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.